U.S., Feb. 15 -- ClinicalTrials.gov registry received information related to the study (NCT06827340) titled 'Multiparametric Whole-Body MRI: a Game Changer in Metastatic Prostate Cancer' on Jan. 10.
Brief Summary: WB-MRI is a next-generation imaging technique standardized with the first version of MET-RADs-P guidelines.This narrative review aims to analyse the main scientific evidence available in the literature, explaining what WB MRI is and showing its decisive role in metastatic PC.
Study Start Date: Jan. 01, 1995
Study Type: OBSERVATIONAL
Condition:
Prostate Cancer (Adenocarcinoma)
Recruitment Status: COMPLETED
Sponsor: IRCCS Azienda Ospedaliero-Universitaria di Bologna
Disclaimer: Curated by HT Syndication....